Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)
Egypt flag Egypt · Delayed Price · Currency is EGP
250.25
-2.75 (-1.09%)
At close: Feb 22, 2026

EGX:CPCI Income Statement

Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
2,2812,0791,3611,0051,1121,062
Revenue Growth (YoY)
33.69%52.80%35.38%-9.61%4.71%5.11%
Cost of Revenue
1,4711,288843.19767.94785.17793.91
Gross Profit
809.77791.47517.66237.3326.95268.13
Selling, General & Admin
132.76138.06116.67103.71101.7587.62
Other Operating Expenses
79.6885.54115.3256.8533.1124.18
Operating Expenses
212.45223.6231.99160.56134.86111.8
Operating Income
597.33567.86285.6776.74192.08156.33
Interest Expense
-16.35-13.54-18.94-3.47--
Interest & Investment Income
22.2621.7114.684.366.873.89
Currency Exchange Gain (Loss)
-12.74-12.7427.8145.83--
Other Non Operating Income (Expenses)
9.139.136.134.0115.142.84
EBT Excluding Unusual Items
599.63572.43315.35127.48214.1163.06
Gain (Loss) on Sale of Assets
2.222.22-00.08--
Pretax Income
601.85574.64315.35127.56214.1163.06
Income Tax Expense
134.95130.9269.2430.4748.3538.75
Earnings From Continuing Operations
466.89443.72246.1197.09165.74124.3
Net Income
466.89443.72246.1197.09165.74124.3
Net Income to Common
466.89443.72246.1197.09165.74124.3
Net Income Growth
25.72%80.29%153.48%-41.42%33.34%13.89%
Shares Outstanding (Basic)
151515151515
Shares Outstanding (Diluted)
151515151515
EPS (Basic)
31.2129.7116.486.5011.108.32
EPS (Diluted)
31.2129.7116.486.5011.108.32
EPS Growth
25.37%80.29%153.48%-41.42%33.34%13.89%
Free Cash Flow
248.2239.2546.659.4534.52138.57
Free Cash Flow Per Share
16.5916.023.120.632.319.28
Dividend Per Share
16.74016.74012.8305.0005.0004.000
Dividend Growth
30.48%30.48%156.60%-25.00%49.25%
Gross Margin
35.51%38.06%38.04%23.61%29.40%25.25%
Operating Margin
26.19%27.31%20.99%7.63%17.27%14.72%
Profit Margin
20.47%21.34%18.09%9.66%14.90%11.70%
Free Cash Flow Margin
10.88%11.51%3.43%0.94%3.10%13.05%
EBITDA
641.44599.51290.9988.3207.25156.77
EBITDA Margin
28.13%28.83%21.38%8.78%18.64%14.76%
D&A For EBITDA
44.1131.655.3211.5615.170.44
EBIT
597.33567.86285.6776.74192.08156.33
EBIT Margin
26.19%27.31%20.99%7.63%17.27%14.72%
Effective Tax Rate
22.42%22.78%21.96%23.88%22.58%23.77%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.